Michael Porter is a Director in the global vaccine technology and engineering group of Merck & Co., Inc. Since 1987, he has held a variety of divisional engineering and supervisory positions within Merck’s Manufacturing Division, focusing on manufacturing, lyophilization, and barrier isolator technology filling of vaccines and sterile pharmaceuticals. Porter is currently responsible for start-up of a new vaccine manufacturing facility in Durham, North Carolina. He has prior experience in plant and process design in the petrochemical industry, and holds a BS in chemical engineering from Villanova University. Porter has been Co-Chair of the ISPE Barrier Isolation Conference for more than a decade. He is a member of ISPE, and has presented on the subjects of barrier isolation and cleanroom automation technologies dozens of times to the pharmaceutical community.